A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
מצבים רפואיים
Solid Tumors Harboring MET Amplification
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Beverly Hills Cancer Center /ID# 275465, Beverly Hills, California, United States
City of Hope National Medical Center /ID# 275613, Duarte, California, United States
Valkyrie Clinical Trials /ID# 275547, Los Angeles, California, United States
Yale University School of Medicine /ID# 275978, New Haven, Connecticut, United States
Florida Cancer Specialists - North /ID# 277137, St. Petersburg, Florida, United States
Northwestern University Feinberg School of Medicine /ID# 276436, Chicago, Illinois, United States
University of Chicago Medical Center /ID# 275342, Chicago, Illinois, United States
START Midwest /ID# 276603, Grand Rapids, Michigan, United States
Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 275999, New York, New York, United States
Duke Cancer Institute /ID# 275604, Durham, North Carolina, United States
SCRI Oncology Partners /ID# 275686, Nashville, Tennessee, United States
UT Southwestern Medical Center /ID# 276053, Dallas, Texas, United States
The University of Texas MD Anderson Cancer Center /ID# 275663, Houston, Texas, United States
South Texas Accelerated Research Therapeutics (START) /ID# 276608, San Antonio, Texas, United States
Start Mountain Region /ID# 276607, West Valley City, Utah, United States
Virginia Cancer Specialists - Fairfax /ID# 276010, Fairfax, Virginia, United States
Rabin Medical Center. /ID# 274341, Petah Tikva, Central District, Israel
The Chaim Sheba Medical Center /ID# 274342, Ramat Gan, Tel Aviv, Israel
Tel Aviv Sourasky Medical Center /ID# 274344, Tel Aviv, Tel Aviv, Israel
Hadassah Medical Center-Hebrew University /ID# 274343, Jerusalem, Israel
Nagoya University Hospital /ID# 276336, Nagoya, Aichi-ken, Japan
National Cancer Center Hospital East /ID# 276298, Kashiwa-shi, Chiba, Japan
Kyushu University Hospital /ID# 276302, Fukuoka, Fukuoka, Japan
Hokkaido University Hospital /ID# 276333, Sapporo, Hokkaido, Japan
Kyoto University Hospital /ID# 276398, Kyoto, Kyoto, Japan
Tohoku University Hospital /ID# 276344, Sendai, Miyagi, Japan
Okayama University Hospital /ID# 276299, Okayama, Okayama-ken, Japan
National Cancer Center Hospital /ID# 276297, Chuo-Ku, Tokyo, Japan
Seoul National University Hospital /ID# 275703, Seoul, Seoul Teugbyeolsi, South Korea
Yonsei University Health System Severance Hospital /ID# 276184, Seoul, Seoul Teugbyeolsi, South Korea
Samsung Medical Center /ID# 275705, Seoul, Seoul Teugbyeolsi, South Korea
מובילי המחקר
ABBVIE INC.
Study Director
AbbVie